Zolpidem Tartrate Tablet
Product Images NDC 43386-762

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 43386-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 01)

Chemical structure depicting zolpidem tartrate, showing the molecular composition of zolpidem and tartaric acid components.*

FDA Label Image

A (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 02)

An instructional illustration labeled Figure A showing a person lying in bed with an alarm clock on a nightstand. The image includes an arrow pointing to a single pouch, indicating use of only one pouch, likely for sublingual zolpidem tartrate tablets.*

FDA Label Image

B (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 03)

A table illustrating the recommended timing for taking Zolpidem Tartrate sublingual tablets based on the time one must be awake, showing corresponding administration times before the target wake-up time.*

FDA Label Image

C (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 04)

Instructional diagram for Zolpidem Tartrate Sublingual Tablet showing how to find the latest dosing time. It includes two images of clocks with colored arrows: a green arrow indicating the earliest time to be awake and a black arrow indicating the latest time to take the tablet. The instructions explain turning the clock wheel to align with the earliest wake time and taking the tablet before the designated time. Additional note advises only taking the tablet if at least 4 hours of bedtime remain.*

FDA Label Image

D (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 05)

An instructional illustration labeled Figure D showing hands opening a small packet or pouch. The image demonstrates how to tear open the packaging, likely related to the administration or dispensing of a medication tablet.*

FDA Label Image

E (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 06)

Illustration showing two hands using scissors to cut a blister pack containing a single tablet. The image is labeled as Figure E and appears to demonstrate how to separate an individual tablet from the blister packaging.*

FDA Label Image

F (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 07)

An instructional diagram labeled Figure F showing a hand placing an empty pouch on a table with a clock in the background, presumably to illustrate a timing or usage step related to the product.*

FDA Label Image

G (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 08)

Illustration showing a person placing a sublingual tablet under the tongue, demonstrating the intended route of administration for zolpidem tartrate sublingual tablets.*

FDA Label Image

1.75-car-1 (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 09)

Packaging label for Zolpidem Tartrate Sublingual Tablet 1.75 mg by Lupin Pharmaceuticals, Inc. The label indicates 30 unit-dose pouches, each containing one sublingual tablet. The label includes directions for sublingual administration only and pharmacist instructions to dispense medication guide and dosing time tool. The label features the NDC 43386-762-30 and dosage form as sublingual tablet.*

FDA Label Image

3.5-car-1 (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 10)

Packaging label for Zolpidem Tartrate Sublingual Tablet 3.5 mg by Lupin Pharmaceuticals, Inc. The carton indicates the product contains 30 unit-dose pouches, each with one sublingual tablet. The label highlights sublingual administration, Rx only status, and includes storage and usage warnings. NDC 43386-761-30 is noted on the packaging.*

FDA Label Image

1.75-pouch (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 11)

Label for Zolpidem Tartrate Sublingual Tablet 1.75 mg by Lupin Pharmaceuticals, Inc. The label includes dosage form as a spearmint-flavored sublingual tablet, strength, and usage instructions. It features a dosing time chart, storage instructions, and warnings not to swallow the tablet whole. The label also shows an Rx-only symbol, NDC 43386-762-01, and the Lupin logo.*

FDA Label Image

3.5-pouch (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 12)

Zolpidem Tartrate Sublingual Tablet 3.5 mg packaging label from Lupin Pharmaceuticals, Inc. The label includes the product name, dosage strength, and indicates spearmint flavor. It provides dosing instructions, warnings against swallowing the tablet whole, and storage guidance. The label also features a dosing time chart and a barcode.*

FDA Label Image

1.75-blister (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 13)

Zolpidem Tartrate 1.75 mg sublingual tablet blister packaging label from Lupin Pharmaceuticals, Inc. The label includes directions to cut the blister at a dotted line to remove the tablet. The label shows the drug name, strength, dosage form, and manufacturer information.*

FDA Label Image

3.5-blister (82e9f9ed 946a 49e0 Be00 A74a0b0b8de2 14)

Label image showing Zolpidem Tartrate sublingual tablets with a strength of 3.5 mg. Produced by Lupin Pharmaceuticals, Inc., the labels include instructions to open the blister pack by cutting at the dotted line. Each label contains regulatory symbols and dosing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.